Differential influence of the calcium antagonist nitrendipine and the vasodilator hydralazine on normal and elevated blood pressure
- PMID: 6476986
Differential influence of the calcium antagonist nitrendipine and the vasodilator hydralazine on normal and elevated blood pressure
Abstract
The relationship between pre-treatment blood pressure and its reduction by the calcium antagonist nitrendipine (NIT) and the vasodilator hydralazine (HYD) was studied in conscious normotensive Wistar Kyoto (WKY) and spontaneously hypertensive rats (SHR). In SHR the correlation was linear and similar after NIT and HYD. In WKY, however, the hypotensive effect of HYD was greater than that of NIT. As revealed by the dose-response curves in SHR both drugs produce similar maximal drops in blood pressure by about 54%. In WKY, HYD also caused a similar relative reduction in blood pressure. In contrast, after NIT initial blood pressure was reduced by only 27% at maximum. The greater hypotensive effect of HYD in WKY is not caused by impaired sympathetic counterregulation since in both substrains tachycardia was more prominent after HYD. Possible mechanisms of the enhanced depressor action of NIT in hypertension are discussed.
Similar articles
-
Hypotensive effects of dihydropyridine derivatives.Arzneimittelforschung. 1985;35(9):1377-80. Arzneimittelforschung. 1985. PMID: 2935160
-
Effect of a new calcium antagonist, nitrendipine, on blood pressure and heart rate of conscious, unrestrained dogs.Arzneimittelforschung. 1981;31(12):2062-4. Arzneimittelforschung. 1981. PMID: 7199298
-
Nitrendipine and other calcium entry blockers (calcium antagonists) in hypertension.Fed Proc. 1983 Feb;42(2):196-200. Fed Proc. 1983. PMID: 6822291
-
Nitrendipine: hemodynamic effects in conscious normotensive and spontaneously hypertensive rats.J Cardiovasc Pharmacol. 1984;6 Suppl 7:S1016-23. J Cardiovasc Pharmacol. 1984. PMID: 6085359
-
Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.J Pharmacol Exp Ther. 1984 Aug;230(2):367-75. J Pharmacol Exp Ther. 1984. PMID: 6146711
Cited by
-
Discovery and Development of Calcium Channel Blockers.Front Pharmacol. 2017 May 29;8:286. doi: 10.3389/fphar.2017.00286. eCollection 2017. Front Pharmacol. 2017. PMID: 28611661 Free PMC article. Review.
-
Nifedipine and hypertension: roles of vasodilation and sodium balance.Cardiovasc Drugs Ther. 1989 Jun;3 Suppl 1:295-301. doi: 10.1007/BF00148474. Cardiovasc Drugs Ther. 1989. PMID: 2487801 Review.
-
Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis.Philos Trans R Soc Lond B Biol Sci. 2005 Dec 29;360(1464):2259-72. doi: 10.1098/rstb.2005.1774. Philos Trans R Soc Lond B Biol Sci. 2005. PMID: 16321796 Free PMC article. Review.
-
Effects of dihydropyridine calcium channel antagonists in ethanol withdrawal; doses required, stereospecificity and actions of Bay K 8644.Psychopharmacology (Berl). 1990;100(3):387-92. doi: 10.1007/BF02244612. Psychopharmacology (Berl). 1990. PMID: 1690434
-
Augmentation by calcium channel antagonists of general anaesthetic potency in mice.Br J Pharmacol. 1986 Aug;88(4):909-14. doi: 10.1111/j.1476-5381.1986.tb16265.x. Br J Pharmacol. 1986. PMID: 2943355 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials